Monday, September 16, 2019


Researchers from the University of Manchester have been able to find a new strategy that could help treat cancer hair loss or hair loss caused by cytotoxic agents such as taxanes that are used in chemotherapy for treating cancer. They say a new class of drugs called CDK4/6 inhibitors could halt cell division in hair follicles in the scalp, preventing hair loss.
The famous Hallmark Channel host – Cameron Mathison – has recently revealed that he has been diagnosed with renal cell carcinoma, or kidney cancer. He shared the news about his diagnosis on his show “Home and Family” on Monday. On Tuesday, he took to Instagram to share the news and asked his fans to help and pray, crediting his family for their love and support.
A new global study has found that early-onset colon cancer has been increasing among younger adults and high-income nations; however, the rates have been steady among older adults. Researchers advise people to check with their doctor of they experience GI symptoms for more two or three weeks.
According to a new study conducted in the United Kingdom, there is a possible link between eating chicken and cancer risk. Researchers from Oxford University have found that eating chicken could increase the risk of non-Hodgkin’s lymphoma, which is a type of blood cancer. They also found that eating chicken is associated with prostate cancer risk in men.
A new study published Thursday in the journal Cancer Research has found that women who experienced PTSD symptoms at least once in their lives are at a greater risk of developing ovarian cancer. Ovarian cancer is difficult to detect, especially in its early stages. Researchers hope that examining PTSD symptoms in women could help prevent ovarian cancer.
Treating childhood cancer has not been a top priority for most nations, especially those with inadequate resources and knowledge. A new study has found that childhood cancer is a much bigger concern and burden than previously recognized. Therefore, US News Journalists traveled three continents to improve care and seek a global solution.
According to a study published last week in the Lancet, women who undergo menopausal hormonal therapy are at higher risk of developing breast cancer and the risk remains high for more than 10 years after stopping the therapy. Post-menopausal women often undergo hormonal therapy because they tend to secrete less hormone after attaining the climacteric age.